エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report:
(Date of earliest event reported)
September 18, 2025
Research Solutions, Inc.
(Exact name of registrant as specified in its charter)
Nevada
(State or other Jurisdiction of Incorporation)
1-39256 |
11-3797644 | |
| (Commission File Number) | (IRS Employer Identification No.) |
N/A1
(Address of Principal Executive Offices and zip code)
(310) 477-0354
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol(s) | Name of each Exchange on which registered |
| Common stock, $0.001 par value | RSSS | The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
1 In November 2019, we became a fully remote company. Accordingly, we do not currently have principal executive offices. Our mailing address is 10624 E. Eastern Ave., Ste. A-614, Henderson, NV 89052.
| Item 2.02 | Results of Operations and Financial Condition. |
On September 18, 2025, the Registrant announced its financial results for the fourth quarter and fiscal year ended June 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits.
Exhibit
Number Description
| 99.1 | Press Release issued September 18, 2025 entitled “Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results”. |
| 104 | Cover Page Interactive Data File (embedded as Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESEARCH SOLUTIONS, INC. | ||
| Date: September 18, 2025 | By: | /s/ William Nurthen |
| William Nurthen | ||
| Chief Financial Officer | ||
Exhibit 99.1
FOR IMMEDIATE RELEASE
Research Solutions Reports Fourth Quarter and Fiscal Year 2025 Results
Reports 36% YoY Platform Revenue Increase, ARR of $20.9 Million and Record Fiscal Year Net Income and Adjusted EBITDA
HENDERSON, Nev., September 18, 2025 — Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2025.
Fiscal Fourth Quarter 2025 Summary (compared to prior-year quarter)
| · | Platform revenue up 21% to $5.2 million. Annual Recurring Revenue (“ARR”) up 20% to $20.9 million, which includes approximately $14.2 million of B2B recurring revenue and $6.7 million of B2C recurring revenue. | |
| · | Total revenue of $12.4 million, a 3% increase. | |
| · | Gross profit up 12%. Total gross margin improved 450 basis points to 51%, crossing 50% on a blended basis for the first time in the Company’s history. | |
| · | Net income of $2.4 million, or $0.07 per diluted share, compared to net loss of $2.8 million or ($0.09) per share. This quarter’s result includes a $1.1 million favorable adjustment related to the final earnout adjustment for Scite. Last year’s result included a negative adjustment charge in other expense of approximately $4.3 million related to the projected earnout for Scite. | |
| · | Adjusted EBITDA increased 15% to a Company record of $1.6 million. | |
| · | Cash flow from operations of $2.3 million, compared to $2.0 million. |
Fiscal Year 2025 Summary (compared to Fiscal 2024)
| · | Platform revenue up 36% to $19.0 million. | |
| · | Total revenue of $49.1 million, a 10% increase. | |
| · | Gross profit up 23%. Total gross margin improved 530 basis points to 49.3%. | |
| · | Net income of $1.3 million, or $0.04 per diluted share, compared to a net loss of $3.8 million, or ($0.13) per share. This year’s result includes $1.7 million of net other expense related to the Scite earn-out compared to $5.1 million of net other expense related to the Scite earnout in fiscal 2024. | |
| · | Adjusted EBITDA of $5.3 million, a Company record, compared to $2.2 million. | |
| · | Cash flow from operations of $7.0 million, a Company record, compared to $3.6 million. The Company ended the fiscal year with $12.2 million in cash and cash equivalents. |
“Fiscal 2025 reflects a year of significant progress in our ongoing SaaS software and AI solution set transition, with our platform revenue now representing nearly 40% of total revenue for the year compared to 31% in fiscal 2024. As expected, this strategic shift and continued focus on recurring revenue has also translated into meaningful increases in gross margin, Adjusted EBITDA and operating cash flow,” said Roy W. Olivier, President and CEO of Research Solutions. “Following the final earnout calculation for Scite, we proactively adjusted the payout structure, offering more cash and reducing dilution to current shareholders. We remain focused on improving on our “Rule of 40” goal, with a slight bias towards increased growth versus profitability, which in turn should create long-term value for our shareholders. In addition, we used the Scite acquisition to help build out the AI capabilities in our product set and we continue to actively pursue additional opportunities that enhance, complement and strengthen our current product offerings. The growth rate of our AI-based Scite product is over 40%, which I view as a good indication that we are on the right track. Lastly, from a cash and Adjusted EBITDA perspective, we are better positioned than we ever have been to execute on these opportunities.”
Fiscal Fourth Quarter 2025 Results
Total revenue was $12.4 million, compared to $12.1 million in the year-ago quarter driven by increased platform revenue versus the prior-year period.
Platform subscription revenue for the quarter was $5.2 million, a 21% year-over-year increase from the prior-year period. The increase was due to organic growth in the core B2C and B2B platforms, with the latter increasing due to a mix of new logo generation and upsell and cross sell into existing customers. The quarter ended with annual recurring revenue of $20.9 million, up 20% year-over-year (see the Company’s definition of annual recurring revenue below).
Transaction revenue was $7.3 million, compared to $7.9 million in the fourth quarter of fiscal 2024. The decrease was due to lower paid order volume. The transaction active customer count for the quarter was 1,338, compared to 1,398 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).
Total gross margin improved 450 basis points from the prior-year quarter to 51.0%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business.
Total operating expenses were $5.1 million, compared to $5.0 million in the fourth quarter of 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced stock compensation expense.
Other income for the quarter was approximately $1.2 million compared to other expense of approximately $3.5 million in the fourth quarter of fiscal 2024. This quarter’s result includes a $1.1 million favorable adjustment related to the final determination of the Scite earnout. Last year’s result included a negative adjustment in other expense of approximately $4.3 million related to the projected earnout for Scite.
Net income in the fourth quarter was $2.4 million, or $0.07 per diluted share, compared to net loss of $2.8 million, or ($0.09) per share, in the prior-year quarter. Adjusted EBITDA was $1.6 million, compared to $1.4 million in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).
Full-Year Fiscal 2025 Results
Total revenue was $49.1 million, a 10% increase from fiscal 2024, driven by increased platform revenue.
Platform subscription revenue for fiscal 2025 was $19.0 million, a 36% year-over-year increase. The increase was primarily due to organic growth in the core B2C and B2B platforms, including 150 net new B2B platform deployments, as well as having a full fiscal year of Scite revenue (versus seven months in fiscal 2024).
Transaction revenue was $30.1 million, compared to $30.7 million in fiscal 2024. The decrease was due to lower paid order volume in the second half of fiscal 2025.
Total gross margin improved 530 basis points from the prior-year to 49.3%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business.
Total operating expenses for the year were $21.7 million, compared to $20.4 million in fiscal 2024. The increase was primarily related to higher sales and marketing expenses offset by reduced general and administrative and stock compensation expenses.
Net income for fiscal 2025 was $1.3 million, or $0.04 per diluted share, compared to net loss of $3.8 million, or ($0.13) per share, in the prior year. Adjusted EBITDA was $5.3 million, compared to $2.2 million in fiscal 2024 (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).
Conference Call
Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.
Date: Thursday, September 18, 2025
Time: 5:00 p.m. ET (2:00 p.m. PT)
Dial-in number: 1-203-518-9783
Conference ID: RESEARCH
The conference call will be broadcast live and available for replay until October 18, 2025 by dialing 1-412-317-6671 and using the replay ID 11159860, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.
Fiscal Fourth Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
| Quarter Ended June 30, | Twelve Months Ended June 30, | |||||||||||||||||||||||||||||||
| 2025 | 2024 | Change | % Change | 2025 | 2024 | Change | % Change | |||||||||||||||||||||||||
| Revenue: | ||||||||||||||||||||||||||||||||
| Platforms | $ | 5,184,864 | $ | 4,277,338 | $ | 907,526 | 21.2 | % | $ | 18,955,695 | $ | 13,956,517 | $ | 4,999,178 | 35.8 | % | ||||||||||||||||
| Transactions | $ | 7,253,053 | $ | 7,856,176 | (603,123 | ) | -7.7 | % | $ | 30,102,286 | $ | 30,667,382 | (565,096 | ) | -1.8 | % | ||||||||||||||||
| Total Revenue | 12,437,917 | 12,133,514 | 304,403 | 2.5 | % | 49,057,981 | 44,623,899 | 4,434,082 | 9.9 | % | ||||||||||||||||||||||
| Gross Profit: | ||||||||||||||||||||||||||||||||
| Platforms | 4,590,639 | 3,650,286 | 940,353 | 25.8 | % | 16,584,155 | 11,889,314 | 4,694,841 | 39.5 | % | ||||||||||||||||||||||
| Transactions | 1,751,263 | 1,992,580 | (241,317 | ) | -12.1 | % | 7,611,796 | 7,750,852 | (139,056 | ) | -1.8 | % | ||||||||||||||||||||
| Total Gross Profit | 6,341,902 | 5,642,866 | 699,036 | 12.4 | % | 24,195,951 | 19,640,166 | 4,555,785 | 23.2 | % | ||||||||||||||||||||||
| Gross profit as a % of revenue: | ||||||||||||||||||||||||||||||||
| Platforms | 88.5 | % | 85.3 | % | 3.2 | % | 87.5 | % | 85.2 | % | 2.3 | % | ||||||||||||||||||||
| Transactions | 24.1 | % | 25.4 | % | -1.2 | % | 25.3 | % | 25.3 | % | 0.0 | % | ||||||||||||||||||||
| Total Gross Profit | 51.0 | % | 46.5 | % | 4.5 | % | 49.3 | % | 44.0 | % | 5.3 | % | ||||||||||||||||||||
| Operating Expenses: | ||||||||||||||||||||||||||||||||
| Sales and marketing | 1,219,184 | 830,195 | 388,989 | 46.9 | % | 5,360,356 | 3,442,503 | 1,917,853 | 55.7 | % | ||||||||||||||||||||||
| Technology and product development | 1,356,801 | 1,489,491 | (132,690 | ) | -8.9 | % | 5,631,344 | 5,442,382 | 188,962 | 3.5 | % | |||||||||||||||||||||
| General and administrative | 2,152,855 | 1,917,907 | 234,948 | 12.3 | % | 7,936,644 | 8,511,697 | (575,053 | ) | -6.8 | % | |||||||||||||||||||||
| Depreciation and amortization | 315,021 | 311,004 | 4,017 | 1.3 | % | 1,245,362 | 836,271 | 409,091 | 48.9 | % | ||||||||||||||||||||||
| Stock-based compensation | 176,611 | 426,190 | (249,579 | ) | -58.6 | % | 1,723,561 | 2,155,461 | (431,900 | ) | -20.0 | % | ||||||||||||||||||||
| Foreign currency translation loss (gain) | (83,322 | ) | 6,336 | (89,658 | ) | NM | (202,527 | ) | 21,395 | (223,922 | ) | NM | ||||||||||||||||||||
| Total Operating Expenses | 5,137,150 | 4,981,123 | 156,027 | 3.1 | % | 21,694,740 | 20,409,709 | 1,285,031 | 6.3 | % | ||||||||||||||||||||||
| Income (loss) from operations | 1,204,752 | 661,743 | 543,009 | 82.1 | % | 2,501,211 | (769,543 | ) | 3,270,754 | NM | ||||||||||||||||||||||
| Other Income (Expenses): | ||||||||||||||||||||||||||||||||
| Other income (expenses) | 1,163,557 | (3,451,948 | ) | 4,615,505 | NM | (1,152,847 | ) | (2,903,983 | ) | 1,751,136 | NM | |||||||||||||||||||||
| Provision for income taxes | (7,995 | ) | (31,022 | ) | 23,027 | -74.2 | % | (82,811 | ) | (113,071 | ) | 30,260 | -26.8 | % | ||||||||||||||||||
| Total Other Income (Expenses): | 1,155,562 | (3,482,970 | ) | 4,638,532 | NM | (1,235,658 | ) | (3,017,054 | ) | 1,781,396 | NM | |||||||||||||||||||||
| Net income (loss) | $ | 2,360,314 | $ | (2,821,227 | ) | 5,181,541 | NM | $ | 1,265,553 | $ | (3,786,597 | ) | 5,052,150 | NM | ||||||||||||||||||
| Adjusted EBITDA | $ | 1,613,062 | $ | 1,405,273 | $ | 207,789 | 14.8 | % | $ | 5,267,607 | $ | 2,243,584 | $ | 3,024,023 | 134.8 | % | ||||||||||||||||
| Quarter Ended June 30, | Twelve Months Ended June 30, | |||||||||||||||||||||||||||||||
| 2025 | 2024 | Change | % Change | 2025 | 2024 | Change | % Change | |||||||||||||||||||||||||
| Platforms: | ||||||||||||||||||||||||||||||||
| B2B ARR (Annual recurring revenue*): | ||||||||||||||||||||||||||||||||
| Beginning of Period | $ | 13,474,074 | $ | 11,653,062 | $ | 1,821,012 | 15.6 | % | $ | 12,060,201 | $ | 9,444,129 | $ | 2,616,072 | 27.7 | % | ||||||||||||||||
| Incremental ARR | 723,524 | 407,139 | 316,385 | 77.7 | % | 2,137,397 | 2,616,072 | (478,675 | ) | -18.3 | % | |||||||||||||||||||||
| End of Period | $ | 14,197,598 | $ | 12,060,201 | $ | 2,137,397 | 17.7 | % | $ | 14,197,598 | $ | 12,060,201 | $ | 2,137,397 | 17.7 | % | ||||||||||||||||
| Deployments: | ||||||||||||||||||||||||||||||||
| Beginning of Period | 1,133 | 983 | 150 | 15.3 | % | 1,021 | 835 | 186 | 22.3 | % | ||||||||||||||||||||||
| Incremental Deployments | 38 | 38 | - | 0.0 | % | 150 | 186 | (36 | ) | -19.4 | % | |||||||||||||||||||||
| End of Period | 1,171 | 1,021 | 150 | 14.7 | % | 1,171 | 1,021 | 150 | 14.7 | % | ||||||||||||||||||||||
| ASP (Average sales price): | ||||||||||||||||||||||||||||||||
| Beginning of Period | $ | 11,892 | $ | 11,855 | $ | 38 | 0.3 | % | $ | 11,812 | $ | 11,310 | $ | 502 | 4.4 | % | ||||||||||||||||
| End of Period | $ | 12,124 | $ | 11,812 | $ | 312 | 2.6 | % | $ | 12,124 | $ | 11,812 | $ | 312 | 2.6 | % | ||||||||||||||||
| B2C ARR (Annual recurring revenue*): | ||||||||||||||||||||||||||||||||
| Beginning of Period | $ | 6,877,926 | $ | 4,902,975 | $ | 1,974,951 | NM | $ | 5,363,129 | $ | - | $ | 5,363,129 | NM | ||||||||||||||||||
| Incremental ARR | (156,570 | ) | 460,154 | (616,724 | ) | NM | 1,358,227 | 5,363,129 | (4,004,902 | ) | NM | |||||||||||||||||||||
| End of Period | $ | 6,721,356 | $ | 5,363,129 | $ | 1,358,227 | 25.3 | % | $ | 6,721,356 | $ | 5,363,129 | $ | 1,358,227 | 25.3 | % | ||||||||||||||||
| Total ARR (Annualized recurring revenue): | $ | 20,918,954 | $ | 17,423,330 | $ | 3,495,624 | 20.1 | % | $ | 20,918,954 | $ | 17,423,330 | $ | 3,495,624 | 20.1 | % | ||||||||||||||||
| Transaction Customers: | ||||||||||||||||||||||||||||||||
| Corporate customers | 1,028 | 1,093 | (65 | ) | -5.9 | % | 1,053 | 1,088 | (35 | ) | -3.2 | % | ||||||||||||||||||||
| Academic customers | 310 | 305 | 5 | 1.6 | % | 320 | 316 | 4 | 1.3 | % | ||||||||||||||||||||||
| Total customers | 1,338 | 1,398 | (60 | ) | -4.3 | % | 1,373 | 1,404 | (31 | ) | -2.2 | % | ||||||||||||||||||||
* Annual Recurring Revenue (Non-GAAP Measure) - the value of contracted platform subscription recurring revenue normalized to a one year period.
For B2C, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by 12.
Active Customer Accounts, Transactions and Annual Recurring Revenue
The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The Company defines annual recurring revenue (“ARR”) as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions’ management evaluates and makes operating decisions using various financial metrics. In addition to the Company’s GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company’s operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other (income) expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
| Quarter Ended June 30, | Twelve Months Ended June 30, | |||||||||||||||||||||||||||||||
| 2025 | 2024 | Change | % Change | 2025 | 2024 | Change | % Change | |||||||||||||||||||||||||
| Net Income (loss) | $ | 2,360,314 | $ | (2,821,227 | ) | $ | 5,181,541 | NM | $ | 1,265,553 | $ | (3,786,597 | ) | $ | 5,052,150 | NM | ||||||||||||||||
| Add (deduct): | - | |||||||||||||||||||||||||||||||
| Other (income) expense | (1,163,557 | ) | 3,451,948 | (4,615,505 | ) | NM | 1,152,847 | 2,903,983 | (1,751,136 | ) | NM | |||||||||||||||||||||
| Foreign currency translation loss (gain) | (83,322 | ) | 6,336 | (89,658 | ) | NM | (202,527 | ) | 21,395 | (223,922 | ) | NM | ||||||||||||||||||||
| Provision for income taxes | 7,995 | 31,022 | (23,027 | ) | -74.2 | % | 82,811 | 113,071 | (30,260 | ) | -26.8 | % | ||||||||||||||||||||
| Depreciation and amortization | 315,021 | 311,004 | 4,017 | 1.3 | % | 1,245,362 | 836,271 | 409,091 | 48.9 | % | ||||||||||||||||||||||
| Stock-based compensation | 176,611 | 426,190 | (249,579 | ) | -58.6 | % | 1,723,561 | 2,155,461 | (431,900 | ) | -20.0 | % | ||||||||||||||||||||
| Adjusted EBITDA | $ | 1,613,062 | $ | 1,405,273 | $ | 207,789 | 14.8 | % | $ | 5,267,607 | $ | 2,243,584 | $ | 3,024,023 | 134.8 | % | ||||||||||||||||
About Research Solutions
Research Solutions, Inc. (NASDAQ: RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com
Important Cautions Regarding Forward-Looking Statements
Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company’s prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.
Research Solutions, Inc. and Subsidiaries
Consolidated Balance Sheets (Unaudited)
| June 30, | June 30, | |||||||
| 2025 | 2024 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 12,227,312 | $ | 6,100,031 | ||||
| Accounts receivable, net of allowance of $182,324 and $68,579, respectively | 7,191,234 | 6,879,800 | ||||||
| Prepaid expenses and other current assets | 580,257 | 643,553 | ||||||
| Prepaid royalties | 925 | 1,067,237 | ||||||
| Total current assets | 19,999,728 | 14,690,621 | ||||||
| Non-current assets: | ||||||||
| Property and equipment, net of accumulated depreciation of $964,883 and $922,558, respectively | 60,769 | 88,011 | ||||||
| Intangible assets, net of accumulated amortization of $2,736,773 and $1,535,310, respectively | 9,686,241 | 10,764,261 | ||||||
| Goodwill | 16,372,979 | 16,315,888 | ||||||
| Deposits and other assets | 957 | 981 | ||||||
| Total assets | $ | 46,120,674 | $ | 41,859,762 | ||||
| Liabilities and Stockholders’ Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | 7,443,757 | $ | 8,843,612 | ||||
| Deferred revenue | 10,702,120 | 9,023,848 | ||||||
| Contingent earnout liability, current portion | 7,363,152 | — | ||||||
| Total current liabilities | 25,509,029 | 17,867,460 | ||||||
| Non-current liabilities: | ||||||||
| Contingent earnout liability, long-term portion | 6,683,488 | 12,298,114 | ||||||
| Total liabilities | 32,192,517 | 30,165,574 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding | — | — | ||||||
| Common stock; $0.001 par value; 100,000,000 shares authorized; 32,479,993 and 32,295,373 shares issued and outstanding, respectively | 32,480 | 32,295 | ||||||
| Additional paid-in capital | 39,059,557 | 38,089,958 | ||||||
| Accumulated deficit | (25,043,693 | ) | (26,309,246 | ) | ||||
| Accumulated other comprehensive loss | (120,187 | ) | (118,819 | ) | ||||
| Total stockholders’ equity | 13,928,157 | 11,694,188 | ||||||
| Total liabilities and stockholders’ equity | $ | 46,120,674 | $ | 41,859,762 | ||||
Research Solutions, Inc. and Subsidiaries
Consolidated Statements of Operations and Other Comprehensive Income (Loss)
(Unaudited)
| Years Ended | ||||||||
| June 30, | ||||||||
| 2025 | 2024 | |||||||
| Revenue: | ||||||||
| Platforms | $ | 18,955,695 | $ | 13,956,517 | ||||
| Transactions | 30,102,286 | 30,667,382 | ||||||
| Total revenue | 49,057,981 | 44,623,899 | ||||||
| Cost of revenue: | ||||||||
| Platforms | 2,371,540 | 2,067,203 | ||||||
| Transactions | 22,490,490 | 22,916,530 | ||||||
| Total cost of revenue | 24,862,030 | 24,983,733 | ||||||
| Gross profit | 24,195,951 | 19,640,166 | ||||||
| Operating expenses: | ||||||||
| Selling, general and administrative | 20,449,378 | 19,573,438 | ||||||
| Depreciation and amortization | 1,245,362 | 836,271 | ||||||
| Total operating expenses | 21,694,740 | 20,409,709 | ||||||
| Income (loss) from operations | 2,501,211 | (769,543 | ) | |||||
| Other income | 595,679 | 333,088 | ||||||
| Change in fair value of contingent earnout liability | (1,748,526 | ) | (3,237,071 | ) | ||||
| Income (loss) before provision for income taxes | 1,348,364 | (3,673,526 | ) | |||||
| Provision for income taxes | (82,811 | ) | (113,071 | ) | ||||
| Net income (loss) | 1,265,553 | (3,786,597 | ) | |||||
| Other comprehensive income (loss): | ||||||||
| Foreign currency translation | (1,368 | ) | (595 | ) | ||||
| Comprehensive income (loss) | $ | 1,264,185 | $ | (3,787,192 | ) | |||
| Basic income (loss) per common share: | ||||||||
| Net income (loss) per share | $ | 0.04 | $ | (0.13 | ) | |||
| Weighted average common shares outstanding | 30,681,187 | 28,863,949 | ||||||
| Diluted income (loss) per common share: | ||||||||
| Net income (loss) per share | $ | 0.04 | $ | (0.13 | ) | |||
| Weighted average common shares outstanding | 31,503,972 | 28,863,949 | ||||||
Research Solutions, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(Unaudited)
| Years Ended | ||||||||
| June 30, | ||||||||
| 2025 | 2024 | |||||||
| Cash flow from operating activities: | ||||||||
| Net income (loss) | $ | 1,265,553 | $ | (3,786,597 | ) | |||
| Adjustment to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 1,245,362 | 836,271 | ||||||
| Stock options expense | 205,457 | 140,150 | ||||||
| Restricted common stock expense | 1,518,104 | 1,994,362 | ||||||
| Modification cost of accelerated vesting of restricted common stock | — | 20,949 | ||||||
| Adjustment to contingent earnout liability | 1,748,526 | 3,237,071 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (341,434 | ) | (344,020 | ) | ||||
| Prepaid expenses and other current assets | 63,296 | (164,579 | ) | |||||
| Prepaid royalties | 1,066,312 | 135,441 | ||||||
| Accounts payable and accrued expenses | (1,426,282 | ) | 560,027 | |||||
| Deferred revenue | 1,678,272 | 921,879 | ||||||
| Net cash provided by operating activities | 7,023,166 | 3,550,954 | ||||||
| Cash flow from investing activities: | ||||||||
| Purchase of property and equipment | (19,261 | ) | (71,510 | ) | ||||
| Payment for acquisition of Resolute, net of cash acquired | — | (2,718,253 | ) | |||||
| Payment for acquisition of Scite, net of cash acquired | — | (7,305,493 | ) | |||||
| Net cash used in investing activities | (19,261 | ) | (10,095,256 | ) | ||||
| Cash flow from financing activities: | ||||||||
| Proceeds from the exercise of stock options | 180,800 | — | ||||||
| Common stock repurchase | (934,577 | ) | (554,202 | ) | ||||
| Payment of contingent acquisition consideration | (124,107 | ) | (351,649 | ) | ||||
| Net cash used in financing activities | (877,884 | ) | (905,851 | ) | ||||
| Effect of exchange rate changes | 1,260 | 4,851 | ||||||
| Net increase (decrease) in cash and cash equivalents | 6,127,281 | (7,445,302 | ) | |||||
| Cash and cash equivalents, beginning of period | 6,100,031 | 13,545,333 | ||||||
| Cash and cash equivalents, end of period | $ | 12,227,312 | $ | 6,100,031 | ||||
| Supplemental disclosures of cash flow information: | ||||||||
| Cash paid for income taxes | $ | 82,811 | $ | 113,071 | ||||
| Non-cash investing and financing activities: | ||||||||
| Contingent consideration accrual on asset acquisition | $ | 31,359 | $ | 32,022 | ||||
Contact
Steven Hooser or John Beisler
Three Part Advisors
(214) 872-2710
shooser@threepa.com; jbeisler@threepa.com
# # #